These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36680769)

  • 1. The predictive validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for moderate- to high-risk cannabis, methamphetamine and opioid use after release from prison.
    Cumming C; Kinner SA; McKetin R; Young JT; Li I; Preen DB
    Addiction; 2023 Jun; 118(6):1107-1115. PubMed ID: 36680769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the Alcohol, Smoking and Substance Involvement Screening Test to predict substance-related hospitalisation after release from prison: A cohort study.
    Cumming C; Kinner SA; McKetin R; Young JT; Li I; Preen DB
    Addiction; 2024 Feb; 119(2):236-247. PubMed ID: 37855049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The health needs of people leaving prison with a history of methamphetamine and/or opioid use.
    Cumming C; Kinner SA; McKetin R; Li I; Preen DB
    Drug Alcohol Rev; 2023 May; 42(4):778-784. PubMed ID: 36917515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India.
    Rao R; Mandal P; Gupta R; Ramshankar P; Mishra A; Ambekar A; Jhanjee S; Dhawan A
    J Subst Abuse Treat; 2016 Feb; 61():13-7. PubMed ID: 26470597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries.
    Humeniuk R; Ali R; Babor T; Souza-Formigoni ML; de Lacerda RB; Ling W; McRee B; Newcombe D; Pal H; Poznyak V; Simon S; Vendetti J
    Addiction; 2012 May; 107(5):957-66. PubMed ID: 22126102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study.
    Chamberlain A; Nyamu S; Aminawung J; Wang EA; Shavit S; Fox AD
    Addict Sci Clin Pract; 2019 Feb; 14(1):7. PubMed ID: 30782211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.
    Gordon MS; Kinlock TW; Schwartz RP; O'Grady KE; Fitzgerald TT; Vocci FJ
    Drug Alcohol Depend; 2017 Mar; 172():34-42. PubMed ID: 28107680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: demand reduction strategies.
    Dolan K; Rodas A; Bode A
    Int J Prison Health; 2015; 11(1):30-8. PubMed ID: 25751705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
    Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
    Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
    Kirwan A; Curtis M; Dietze P; Aitken C; Woods E; Walker S; Kinner S; Ogloff J; Butler T; Stoové M
    J Urban Health; 2019 Jun; 96(3):400-410. PubMed ID: 30989484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study.
    Karamouzian M; Buxton JA; Hategeka C; Nosova E; Hayashi K; Milloy MJ; Kerr T
    Int J Drug Policy; 2022 Nov; 109():103852. PubMed ID: 36122483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse to smoking following release from smoke-free correctional facilities in Queensland, Australia.
    Puljević C; de Andrade D; Coomber R; Kinner SA
    Drug Alcohol Depend; 2018 Jun; 187():127-133. PubMed ID: 29660697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using ICD-10-CM codes to detect illicit substance use: A comparison with retrospective self-report.
    Rowe CL; Santos GM; Kornbluh W; Bhardwaj S; Faul M; Coffin PO
    Drug Alcohol Depend; 2021 Apr; 221():108537. PubMed ID: 33621806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Trends in Alcohol and Other Drug Use Among Police Detainees in New Zealand, 2010-2015.
    Wilkins C; Prasad J; Parker K; Rychert M; Barnes HM
    Curr Top Behav Neurosci; 2017; 34():161-172. PubMed ID: 28434182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients.
    Gryczynski J; Kelly SM; Mitchell SG; Kirk A; O'Grady KE; Schwartz RP
    Addiction; 2015 Feb; 110(2):240-7. PubMed ID: 25311148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Mental Health Needs, Substance Use, and Co-occurring Disorders Among People Admitted to Prison.
    Butler A; Nicholls T; Samji H; Fabian S; Lavergne MR
    Psychiatr Serv; 2022 Jul; 73(7):737-744. PubMed ID: 34809437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for heroin use following release from jail or prison in adults in a Central Appalachian state between 2012-2017.
    Smith KE; Archuleta A; Staton M; Winston E
    Am J Drug Alcohol Abuse; 2020; 46(4):485-497. PubMed ID: 33223579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
    Larney S; Toson B; Burns L; Dolan K
    Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment.
    Curtis M; Winter RJ; Dietze P; Wilkinson AL; Cossar RD; Stewart AC; Agius PA; Butler T; Aitken C; Kirwan A; Walker S; Stoové M
    Addiction; 2022 Nov; 117(11):2887-2898. PubMed ID: 35665554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for delivering the UK's multi-centre prison-based naloxone-on-release pilot randomised trial (N-ALIVE): Europe's largest prison-based randomised controlled trial.
    Meade AM; Bird SM; Strang J; Pepple T; Nichols LL; Mascarenhas M; Choo L; Parmar MKB
    Drug Alcohol Rev; 2018 May; 37(4):487-498. PubMed ID: 28940805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.